The U.S. Food and Drug Administration on Friday declined to approve Replimune’s drug for advanced skin cancer, citing insufficient data from studies, a letter from the…
Reuters Health Information
Source link : https://www.medscape.com/s/viewarticle/replimunes-drug-advanced-skin-cancer-fails-win-fda-nod-again-2026a1000b14?src=rss
Author :
Publish date : 2026-04-10 15:24:00
Copyright for syndicated content belongs to the linked Source.
